| 产品详情 |
| Edit |   |
|---|
| Product Name | BMS 303141 |
|---|
| Description | ATP citrate lyase (ACL) inhibitor (IC50 = 0.13 μM for human recombinant ACL); blocks lipid synthesis (IC50 = 8 μM in HepG2 cells). Displays no cytotoxicity up to a concentration of 50 μM. Lowers plasma glucose and triglycerides in a mouse model of hyperlipidemia. Orally bioavailable. Purity 99%. MW (observed): 424.3 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3,5-Dichloro-2-hydroxy-N-(4-methoxy[1,1'-biphenyl]-3-yl)-benzenesulfonamide |
|---|
| Gene, Accession, CAS # | CAS: 943962-47-8 |
|---|
| Catalog # | 4609/50 |
|---|
| Price | |
|---|
| Order / More Info | BMS 303141 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 27248322 |
|---|
| 产品资料 |
|
|